Transcription to follow: If theyre skeptical, its usually because they dont really know a lot of the facts behind the reason for why I do what I do. Theyre usually really responsive to learning a little bit about the cannabinoid system. Theyre very open to understanding that the endogenous cannabinoid system exists. That taking in plant derived or synthetic or prescription pharmaceutical cannabinoids is modulating an existing system, that it is an important system for human physiology and that really, what we are doing with research is discovering new tools to try to utilize this system as a way of improving peoples quality of life. And that usually they recognize the fact that we are limited in terms of therapys that we have available. I work in a chronic pain clinic. So we are limited in terms of pain therapies that we can offer patients. So there is whats called a therapeutic need, an unmet therapeutic need. And so this is simply a new avenue that is opening up for us to explore. Now some of the tools that we have to explore this avenue are you might call blunt tools. Single agent cannabinoids, synthetic single agent cannabinoids, and herbal cannabis. Through it's delivery system that which may be considered a dirty one, if you like smoking or getting cleaned up a bit with vaporizers and so on. But it is in the early days in finding other ways of administering herbal cannabis. But I think we are at the beginning of a new way of thinking about disease and a new way of approaching it. So I think they usually very grateful to have some knowledge, and some explanation as to what the real basic scientific understanding is. And the other thing I tell them is that there is another stream coming in to this, which is the patient stepping up saying listen, Ive been using this, and I have been using this for a long time and when you couple the patient reports with the basic science knowledge there is a mechanism of why they are telling us that this works. You get this beautiful sort of synchronicity of, patients are saying this helps, basic science is saying this stuff looks fantastic, you guys should study this in the clinic. And now we have the opportunity to do that with existing pharmaceuticals, with herbal cannabis products that are quality controlled and so on. So its more of a question of saying were not here to advocate that everyone will benefit, its not a miracle drug for everybody. But there are clearly patients who may be cannabinoid responsive. Here are some tools to help you work with those patients. And some ways you can deal with, and interact with them and educate them. For a lot of physicians who are skeptical, its because they dont know. Its because they feel like their patients are coming in and telling them about this than they know themselves. And that for many physicians may be a challenge to their egos if you like. They feel like hey whoa, I should be the one with the knowledge. So theyre very comfortable to get that information. And to that extent, we have begun a series of physician education programs in Canada. Based on the knowledge base that is now generated. In the last 10 years in cannabis research, in cannabinoid research in general, we now know way more now than we did 10 years ago. There are clinical trials in MS, in Fibromyalgia, in Rheumatoid Arthritis, in cancer pain, in neuropathic pain, which didnt exist 10 years ago. So when you show them the data, they start to think well, thats the language I can speak. I get that now. So they begin to see the evidence, and that is important. So what were doing is taking this knowledge and translating it out in to the community, knowledge transfer. Out to the primary and specialist physicians in the Canadian landscape. From coast to coast, through small case base, accredited CME activity. And this has been a fabulously successful project. Its fascinating to hear physicians come and sit around and tell stories theyve had, the successes they have had, with some of the pharmaceutical drugs, some of the herbal cannabis, with the medical marijuana programs. Having them interact and teach each other has been a very rewarding experience.

Be the first to comment